Corbion NV (CRBN) AI Stock Analysis

• Market Cap: €970.63M
• Dividend Yield: 3.8%
• Average Volume (3M): 127.27K
• Price to Earnings (P/E): 14.3
• Beta (1Y): 1.28
• Revenue Growth: -3.45%
• EPS Growth: -5.55%
• Country: NL
• Employees: 2,383
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Chemicals - Specialty
• EPS (TTM): 0.73
• Shares Outstanding: 58,250,310
• 10 Day Avg. Volume: 140,227
• 30 Day Avg. Volume: 127,270
• PEG Ratio: 0.04
• Price to Book (P/B): 1.63
• Price to Sales (P/S): 0.98
• P/FCF Ratio: 12.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €21.38
• Price Target Upside: 26.28% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4

• Rating: 66 Neutral
• Price Target: €18.00 ▲(6.32% Upside)

Corbion NV's overall stock score is driven by strong financial performance and fair valuation. However, technical indicators suggest bearish momentum, which impacts the overall score. The absence of earnings call data and corporate events limits additional insights.

Corbion NV Business Overview & Revenue Model

Company Description

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.

How the Company Makes Money

Corbion NV generates revenue through multiple key streams, primarily from the sale of ingredients and solutions to the food and biochemicals industries. The company’s food segment includes products such as emulsifiers, preservation agents, and functional ingredients that improve food safety and quality, while its biochemicals segment focuses on lactic acid and its derivatives used in various applications, including bioplastics and pharmaceuticals. Significant partnerships with food manufacturers and companies in the bioplastics industry further enhance its market reach and revenue potential. Additionally, Corbion's commitment to sustainability and innovation allows it to tap into growing consumer trends favoring eco-friendly and health-conscious products, bolstering its earnings through premium pricing and increased demand.

Corbion NV Financial Statement Overview

Summary

Corbion NV demonstrates strong profitability improvements with a net profit margin increase to 14.9% and a high return on equity of 24.9%. However, revenue decline and high debt levels pose challenges. Cash flow generation has improved, but conversion from net income remains moderate.

Income Statement

Corbion NV shows a mixed performance in its income statement. The gross profit margin for the latest year is approximately 24.2%, indicating a strong ability to convert revenue into gross profit. However, the net profit margin has improved significantly to approximately 14.9% from the previous year's 5.0%, driven by increased net income. The revenue growth rate shows a decline of 10.8% from the previous year, suggesting challenges in maintaining top-line growth. The EBIT and EBITDA margins are 6.0% and 13.4% respectively, reflecting efficient operational management despite the revenue decline.

Balance Sheet

The balance sheet presents a stable but leveraged financial position. The debt-to-equity ratio is approximately 0.66, indicating moderate leverage. The return on equity stands high at 24.9%, showcasing effective use of shareholders' capital to generate earnings. The equity ratio is 50%, pointing to a well-balanced asset financing structure through equity and liabilities. However, the high debt levels pose a potential risk in a fluctuating market environment.

Cash Flow

The cash flow statement highlights some concerns. The free cash flow growth has been positive, with an increase from €16.1 million to €99.9 million, indicating improved cash generation capability. However, the operating cash flow to net income ratio of 0.96 suggests less cash generation relative to net income, potentially due to working capital needs or other operational factors. The free cash flow to net income ratio stands at 0.52, showing moderate conversion of net income into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.30B	1.29B	1.44B	1.46B	1.07B	986.50M
Gross Profit	334.30M	312.10M	305.40M	324.30M	265.80M	269.80M
EBITDA	198.50M	172.00M	198.00M	194.00M	140.10M	154.90M
Net Income	68.30M	192.20M	72.90M	90.00M	78.30M	73.10M
Balance Sheet
Total Assets	1.45B	1.55B	1.70B	1.72B	1.36B	1.09B
Cash, Cash Equivalents and Short-Term Investments	40.10M	49.30M	70.20M	58.20M	42.20M	51.60M
Total Debt	494.30M	509.20M	785.50M	759.20M	503.20M	335.80M
Total Liabilities	727.30M	773.80M	1.06B	1.10B	806.50M	578.20M
Stockholders Equity	726.20M	772.50M	636.20M	625.70M	554.10M	516.00M
Cash Flow
Free Cash Flow	99.80M	99.90M	16.10M	-182.60M	-122.00M	24.50M
Operating Cash Flow	168.50M	184.10M	165.40M	53.20M	26.70M	113.40M
Investing Cash Flow	-142.80M	166.00M	-146.80M	-213.30M	-123.70M	-81.30M
Financing Cash Flow	-38.60M	-371.70M	-5.30M	173.90M	85.90M	-23.90M

Corbion NV Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 16.93
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:CRBN, the sentiment is Neutral. The current price of 16.93 is above the 20-day moving average (MA) of 16.80, above the 50-day MA of 16.88, and below the 200-day MA of 18.93, indicating a neutral trend. The MACD of -0.14 indicates Negative momentum. The RSI at 49.30 is Neutral, neither overbought nor oversold. The STOCH value of 63.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NL:CRBN.

Corbion NV Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRBN	66 Neutral	€970.63M	14.28	8.84%	3.80%	-3.45%	-5.55%
AKZA	65 Neutral	€10.25B	24.68	9.60%	3.30%	-1.57%	-29.52%
FFARM	64 Neutral	€399.86M	7.80	16.22%	4.41%	8.76%	193.06%
IMCD	63 Neutral	€5.42B	20.06	14.32%	2.34%	6.09%	-7.18%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
AVTX	41 Neutral	€187.24M	―	-26.08%	―	-12.31%	23.77%
OCI	39 Underperform	€804.82M	58.27	―	75.99%	―	―